
The Next Ozempic Isn't Approved Yet. People Are Already Injecting It.
Retatrutide is outperforming Ozempic and Mounjaro in trials — and it's still years from a pharmacy shelf. That gap hasn't stopped a black market from forming around it.
Stories and research exploring how metabolism changes with age, why weight management gets harder after forty, and what the science actually says about hormones, muscle mass, and energy balance.

Retatrutide is outperforming Ozempic and Mounjaro in trials — and it's still years from a pharmacy shelf. That gap hasn't stopped a black market from forming around it.

A landmark study of 6,400 people found metabolism stays remarkably stable through most of adulthood. Here's what actually changes instead.

As appetite shrinks on a GLP-1 medication, every bite has to work harder. Here's why protein is the nutrient most likely to fall short.

GLP-1 medications already answer the 'eat less' question. The one nobody's asking is whether smaller meals are still covering what your body actually needs.

Weight doesn't just 'get harder to lose' after forty — hormonal and muscle-mass shifts change where fat is stored, and why. Here's what the evidence actually shows.
Stories and research on nerve health, mobility, balance, and the physical changes that affect how confidently people move through daily life after 40.
1 storyExplore Mobility & Nerve HealthStories and research on oral hygiene, the oral microbiome, and how dental health connects to broader wellness.
1 storyExplore Oral HealthStories and research on how sleep architecture shifts with age, why deep sleep becomes harder to reach after midlife, and evidence-based approaches to better rest.
0 storiesExplore SleepReceive one evidence-based wellness story every week.
No pressure, unsubscribe anytime. See our Privacy Policy.